Lamictal

Lamotrigine, the active ingredient in Lamictal, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of focal and generalized seizures in epilepsy and as a mood stabilizer for the maintenance therapy of bipolar disorder, reducing seizure frequency and helping to prevent depressive and manic episodes in adult patients.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity across global markets.

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting neuronal excitability.

- Focal seizures: reduces frequency of partial onset seizures. - Generalized seizures: helps control tonic‑clonic and absence seizures. - Bipolar disorder: maintains mood stability and prevents depressive or manic episodes.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Rash or mild skin irritation. - Headache. - Dizziness or vertigo. - Nausea or gastrointestinal discomfort. - Fatigue or somnolence.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Aseptic meningitis. - Severe hypersensitivity reactions, including anaphylaxis. - Blood dyscrasias such as agranulocytosis. - Hepatic dysfunction.

When prescribing lamotrigine, clinicians should consider several safety measures.

- Dose titration: increase gradually to reduce rash risk. - Skin reactions: monitor for any rash, especially during early treatment. - Hepatic impairment: assess liver function and adjust if needed. - Concomitant valproate: avoid rapid titration as it raises lamotrigine levels. - Pregnancy: discuss potential risks and benefits with the prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels – avoid co‑administration without dose adjustment. - Carbamazepine: reduces lamotrigine levels – may require dose increase. - Phenobarbital: lowers lamotrigine concentrations, potentially reducing efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: can lower lamotrigine levels – monitor seizure control. - Serotonergic agents: risk of serotonin syndrome – observe for symptoms. - Other antiepileptics (phenytoin, primidone): may modify lamotrigine levels and require monitoring.